Artificial Intelligence (AI) In Drug Discovery Market Size, Share, Growth 2032

• CHAPTER NO. 1. INTRODUCTION
  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. USP & Key Offerings
  • 1.2. Key Benefits for Stakehulders
  • 1.3. Target Audience
  • 1.4. Report Scope
• CHAPTER NO. 2. EXECUTIVE SUMMARY
  • 2.1. Key Findings
    • 2.1.1. Top Investment Pockets
      • 2.1.1.1. Market Attractiveness Analysis, By Drug Type
      • 2.1.1.2. Market Attractiveness Analysis, By Offering
      • 2.1.1.3. Market Attractiveness Analysis, By Application
      • 2.1.1.4. Market Attractiveness Analysis, By End User
      • 2.1.1.5. Market Attractiveness Analysis, By Region
  • 2.2. Market Snapshot
  • 2.3. Global Artificial Intelligence (AI) In Drug Discovery Market, 2016 – 2028 (USD Million)
  • 2.4. Insights from Primary Respondents
• CHAPTER NO. 3. COVID 19 IMPACT ANALYSIS
  • 3.1. Impact Assessment of COVID-19 Pandemic, By Region
    • 3.1.1. North America
    • 3.1.2. Europe
    • 3.1.3. Asia Pacific
    • 3.1.4. Latin America
    • 3.1.5. The Middle-East and Africa
  • 3.2. Quarterly Market Revenue and Forecast by Region 2020 & 2021
  • 3.3. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Million)
  • 3.4. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Million)
  • 3.5. Key Strategies Undertaken by Companies to Tackle COVID-19
    • 3.5.1. Company Quarterly Revenue Analysis, 2019 & 2020
  • 3.6. Short Term Dynamics
  • 3.7. Long Term Dynamics
• CHAPTER NO. 4. ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET – BY DRUG TYPE SEGMENT ANALYSIS
  • 4.1. Overview
    • 4.1.1. Market Revenue Share, By Drug Type, 2020 & 2028
  • 4.2. Large Mulecules
    • 4.2.1. Market Size and Forecast, By Region (USD Million)
    • 4.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 4.2.3. Key Market Trends, Growth Factors, & Opportunities
  • 4.3. Small Mulecules
    • 4.3.1. Market Size and Forecast, By Region (USD Million)
    • 4.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 4.3.3. Key Market Trends, Growth Factors, & Opportunities
• CHAPTER NO. 5. ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET – OFFERING SEGMENT ANALYSIS
  • 5.1. Overview
    • 5.1.1. Market Revenue Share, By Offering, 2020 & 2028
  • 5.2. Software
    • 5.2.1. Market Size and Forecast, By Region (USD Million)
    • 5.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 5.2.3. Key Market Trends, Growth Factors, & Opportunities
  • 5.3. Services
    • 5.3.1. Market Size and Forecast, By Region (USD Million)
    • 5.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 5.3.3. Key Market Trends, Growth Factors, & Opportunities
• CHAPTER NO. 6. ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET – APPLICATION SEGMENT ANALYSIS
  • 6.1. Overview
    • 6.1.1. Market Revenue Share, By Application, 2020 & 2028
  • 6.2. Immuno-onculogy
    • 6.2.1. Market Size and Forecast, By Region (USD Million)
    • 6.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 6.2.3. Key Market Trends, Growth Factors, & Opportunities
  • 6.3. Neurodegenerative Diseases
    • 6.3.1. Market Size and Forecast, By Region (USD Million)
    • 6.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 6.3.3. Key Market Trends, Growth Factors, & Opportunities
  • 6.4. Cardiovascular Diseases
    • 6.4.1. Market Size and Forecast, By Region (USD Million)
    • 6.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 6.4.3. Key Market Trends, Growth Factors, & Opportunities
  • 6.5. Metabulic Diseases
    • 6.5.1. Market Size and Forecast, By Region (USD Million)
    • 6.5.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 6.5.3. Key Market Trends, Growth Factors, & Opportunities
  • 6.6. Other Applications
    • 6.6.1. Market Size and Forecast, By Region (USD Million)
    • 6.6.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 6.6.3. Key Market Trends, Growth Factors, & Opportunities
• CHAPTER NO. 7. ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET – END USER SEGMENT ANALYSIS
  • 7.1. Overview
    • 7.1.1. Market Revenue Share, By End User, 2020 & 2028
  • 7.2. Pharmaceutical & Biotechnulogy Companies
    • 7.2.1. Market Size and Forecast, By Region (USD Million)
    • 7.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 7.2.3. Key Market Trends, Growth Factors, & Opportunities
  • 7.3. Contract Research Organizations
    • 7.3.1. Market Size and Forecast, By Region (USD Million)
    • 7.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 7.3.3. Key Market Trends, Growth Factors, & Opportunities
  • 7.4. Research Centers and Academic & Government Institutes
    • 7.4.1. Market Size and Forecast, By Region (USD Million)
    • 7.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 7.4.3. Key Market Trends, Growth Factors, & Opportunities
• CHAPTER NO. 8. ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET – REGIONAL ANALYSIS
  • 8.1. Overview
    • 8.1.1. Global Market Revenue Share, By Region, 2020 & 2028
    • 8.1.2. Global Market Revenue, By Region, 2016 – 2028 (USD Million)
  • 8.2. North America
    • 8.2.1. North America Market Revenue, By Country, 2016 – 2028 (USD Million)
    • 8.2.2. North America Market Revenue, By Drug Type, 2016 – 2028
    • 8.2.3. North America Market Revenue, By Offering, 2016 – 2028
    • 8.2.4. North America Market Revenue, By Application, 2016 – 2028
    • 8.2.5. North America Market Revenue, By End User, 2016 – 2028
    • 8.2.6. U.S.
      • 8.2.6.1. U.S. Market Revenue, By Drug Type, 2016 – 2028
      • 8.2.6.2. U.S. Market Revenue, By Offering, 2016 – 2028
      • 8.2.6.3. U.S. Market Revenue, By Application, 2016 – 2028
      • 8.2.6.4. U.S. Market Revenue, By End User, 2016 – 2028
    • 8.2.7. Canada
      • 8.2.7.1. Canada Market Revenue, By Drug Type, 2016 – 2028
      • 8.2.7.2. Canada Market Revenue, By Offering, 2016 – 2028
      • 8.2.7.3. Canada Market Revenue, By Application, 2016 – 2028
      • 8.2.7.4. Canada Market Revenue, By End User, 2016 – 2028
    • 8.2.8. Mexico
      • 8.2.8.1. Mexico Market Revenue, By Drug Type, 2016 – 2028
      • 8.2.8.2. Mexico Market Revenue, By Offering, 2016 – 2028
      • 8.2.8.3. Mexico Market Revenue, By Application, 2016 – 2028
      • 8.2.8.4. Mexico Market Revenue, By End User, 2016 – 2028
  • 8.3. Europe
    • 8.3.1. Europe Market Revenue, By Country, 2016 – 2028 (USD Million)
    • 8.3.2. Europe Market Revenue, By Drug Type, 2016 – 2028
    • 8.3.3. Europe Market Revenue, By Offering, 2016 – 2028
    • 8.3.4. Europe Market Revenue, By Application, 2016 – 2028
    • 8.3.5. Europe Market Revenue, By End User, 2016 – 2028
    • 8.3.6. Germany
      • 8.3.6.1. Germany Market Revenue, By Drug Type, 2016 – 2028
      • 8.3.6.2. Germany Market Revenue, By Offering, 2016 – 2028
      • 8.3.6.3. Germany Market Revenue, By Application, 2016 – 2028
      • 8.3.6.4. Germany Market Revenue, By End User, 2016 – 2028
    • 8.3.7. France
      • 8.3.7.1. France Market Revenue, By Drug Type, 2016 – 2028
      • 8.3.7.2. France Market Revenue, By Offering, 2016 – 2028
      • 8.3.7.3. France Market Revenue, By Application, 2016 – 2028
      • 8.3.7.4. France Market Revenue, By End User, 2016 – 2028
    • 8.3.8. U.K.
      • 8.3.8.1. U.K. Market Revenue, By Drug Type, 2016 – 2028
      • 8.3.8.2. U.K. Market Revenue, By Offering, 2016 – 2028
      • 8.3.8.3. U.K. Market Revenue, By Application, 2016 – 2028
      • 8.3.8.4. U.K. Market Revenue, By End User, 2016 – 2028
    • 8.3.9. Italy
      • 8.3.9.1. Italy Market Revenue, By Drug Type, 2016 – 2028
      • 8.3.9.2. Italy Market Revenue, By Offering, 2016 – 2028
      • 8.3.9.3. Italy Market Revenue, By Application, 2016 – 2028
      • 8.3.9.4. Italy Market Revenue, By End User, 2016 – 2028
    • 8.3.10. Spain
      • 8.3.10.1. Spain Market Revenue, By Drug Type, 2016 – 2028
      • 8.3.10.2. Spain Market Revenue, By Offering, 2016 – 2028
      • 8.3.10.3. Spain Market Revenue, By Application, 2016 – 2028
      • 8.3.10.4. Spain Market Revenue, By End User, 2016 – 2028
    • 8.3.11. Rest of Europe
      • 8.3.11.1. Rest of Europe Market Revenue, By Drug Type, 2016 – 2028
      • 8.3.11.2. Rest of Europe Market Revenue, By Offering, 2016 – 2028
      • 8.3.11.3. Rest of Europe Market Revenue, By Application, 2016 – 2028
      • 8.3.11.4. Rest of Europe Market Revenue, By End User, 2016 – 2028
  • 8.4. Asia Pacific
    • 8.4.1. Asia Pacific Market Revenue, By Country, 2016 – 2028 (USD Million)
    • 8.4.2. Asia Pacific Market Revenue, By Drug Type, 2016 – 2028
    • 8.4.3. Asia Pacific Market Revenue, By Offering, 2016 – 2028
    • 8.4.4. Asia Pacific Market Revenue, By Application, 2016 – 2028
    • 8.4.5. Asia Pacific Market Revenue, By End User, 2016 – 2028
    • 8.4.6. China
      • 8.4.6.1. China Market Revenue, By Drug Type, 2016 – 2028
      • 8.4.6.2. China Market Revenue, By Offering, 2016 – 2028
      • 8.4.6.3. China Market Revenue, By Application, 2016 – 2028
      • 8.4.6.4. China Market Revenue, By End User, 2016 – 2028
    • 8.4.7. Japan
      • 8.4.7.1. Japan Market Revenue, By Drug Type, 2016 – 2028
      • 8.4.7.2. Japan Market Revenue, By Offering, 2016 – 2028
      • 8.4.7.3. Japan Market Revenue, By Application, 2016 – 2028
      • 8.4.7.4. Japan Market Revenue, By End User, 2016 – 2028
    • 8.4.8. India
      • 8.4.8.1. India Market Revenue, By Drug Type, 2016 – 2028
      • 8.4.8.2. India Market Revenue, By Offering, 2016 – 2028
      • 8.4.8.3. India Market Revenue, By Application, 2016 – 2028
      • 8.4.8.4. India Market Revenue, By End User, 2016 – 2028
    • 8.4.9. South Korea
      • 8.4.9.1. South Korea Market Revenue, By Drug Type, 2016 – 2028
      • 8.4.9.2. South Korea Market Revenue, By Offering, 2016 – 2028
      • 8.4.9.3. South Korea Market Revenue, By Application, 2016 – 2028
      • 8.4.9.4. South Korea Market Revenue, By End User, 2016 – 2028
    • 8.4.10. South-East Asia
      • 8.4.10.1. South-East Asia Market Revenue, By Drug Type, 2016 – 2028
      • 8.4.10.2. South-East Asia Market Revenue, By Offering, 2016 – 2028
      • 8.4.10.3. South-East Asia Market Revenue, By Application, 2016 – 2028
      • 8.4.10.4. South-East Asia Market Revenue, By End User, 2016 – 2028
    • 8.4.11. Rest of Asia Pacific
      • 8.4.11.1. Rest of Asia Pacific Market Revenue, By Drug Type, 2016 – 2028
      • 8.4.11.2. Rest of Asia Pacific Market Revenue, By Offering, 2016 – 2028
      • 8.4.11.3. Rest of Asia Pacific Market Revenue, By Application, 2016 – 2028
      • 8.4.11.4. Rest of Asia Pacific Market Revenue, By End User, 2016 – 2028
  • 8.5. Latin America
    • 8.5.1. Latin America Market Revenue, By Country, 2016 – 2028 (USD Million)
    • 8.5.2. Latin America Market Revenue, By Drug Type, 2016 – 2028
    • 8.5.3. Latin America Market Revenue, By Offering, 2016 – 2028
    • 8.5.4. Latin America Market Revenue, By Application, 2016 – 2028
    • 8.5.5. Latin America Market Revenue, By End User, 2016 – 2028
    • 8.5.6. Brazil
      • 8.5.6.1. Brazil Market Revenue, By Drug Type, 2016 – 2028
      • 8.5.6.2. Brazil Market Revenue, By Offering, 2016 – 2028
      • 8.5.6.3. Brazil Market Revenue, By Application, 2016 – 2028
      • 8.5.6.4. Brazil Market Revenue, By End User, 2016 – 2028
    • 8.5.7. Argentina
      • 8.5.7.1. Argentina Market Revenue, By Drug Type, 2016 – 2028
      • 8.5.7.2. Argentina Market Revenue, By Offering, 2016 – 2028
      • 8.5.7.3. Argentina Market Revenue, By Application, 2016 – 2028
      • 8.5.7.4. Argentina Market Revenue, By End User, 2016 – 2028
    • 8.5.8. Rest of Latin America
      • 8.5.8.1. Rest of Latin America Market Revenue, By Drug Type, 2016 – 2028
      • 8.5.8.2. Rest of Latin America Market Revenue, By Offering, 2016 – 2028
      • 8.5.8.3. Rest of Latin America Market Revenue, By Application, 2016 – 2028
      • 8.5.8.4. Rest of Latin America Market Revenue, By End User, 2016 – 2028
  • 8.6. The Middle-East and Africa
    • 8.6.1. The Middle-East and Africa Market Revenue, By Country, 2016 – 2028 (USD Million)
    • 8.6.2. The Middle-East and Africa Market Revenue, By Drug Type, 2016 – 2028
    • 8.6.3. The Middle-East and Africa Market Revenue, By Offering, 2016 – 2028
    • 8.6.4. The Middle-East and Africa Market Revenue, By Application, 2016 – 2028
    • 8.6.5. The Middle-East and Africa Market Revenue, By End User, 2016 – 2028
    • 8.6.6. GCC Countries
      • 8.6.6.1. GCC Countries Market Revenue, By Drug Type, 2016 – 2028
      • 8.6.6.2. GCC Countries Market Revenue, By Offering, 2016 – 2028
      • 8.6.6.3. GCC Countries Market Revenue, By Application, 2016 – 2028
      • 8.6.6.4. GCC Countries Market Revenue, By End User, 2016 – 2028
    • 8.6.7. South Africa
      • 8.6.7.1. South Africa Market Revenue, By Drug Type, 2016 – 2028
      • 8.6.7.2. South Africa Market Revenue, By Offering, 2016 – 2028
      • 8.6.7.3. South Africa Market Revenue, By Application, 2016 – 2028
      • 8.6.7.4. South Africa Market Revenue, By End User, 2016 – 2028
    • 8.6.8. Rest of Middle-East Africa
      • 8.6.8.1. Rest of Middle-East Africa Market Revenue, By Drug Type, 2016 – 2028
      • 8.6.8.2. Rest of Middle-East Africa Market Revenue, By Offering, 2016 – 2028
      • 8.6.8.3. Rest of Middle-East Africa Market Revenue, By Application, 2016 – 2028
      • 8.6.8.4. Rest of Middle-East Africa Market Revenue, By End User, 2016 – 2028
• CHAPTER NO. 9. ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET – INDUSTRY ANALYSIS
  • 9.1. Introduction
  • 9.2. Market Drivers
    • 9.2.1. Driving Factor 1 Analysis
    • 9.2.2. Driving Factor 2 Analysis
  • 9.3. Market Restraints
    • 9.3.1. Restraining Factor Analysis
  • 9.4. Market Opportunities
    • 9.4.1. Market Opportunity Analysis
  • 9.5. Porter’s Five Forces Analysis
  • 9.6. PEST Analysis
  • 9.7. Regulatory Landscape
  • 9.8. Technology Landscape
  • 9.9. Regional Market Trends
    • 9.9.1. North America
    • 9.9.2. Europe
    • 9.9.3. Asia Pacific
    • 9.9.4. Latin America
    • 9.9.5. The Middle-East and Africa
  • 9.10. Pricing Analysis
  • 9.11. Value Chain Analysis
  • 9.12. Downstream Buyers
  • 9.13. Distributors/Traders List
• CHAPTER NO. 10. COMPETITIVE LANDSCAPE
  • 10.1. Company Market Share Analysis – 2019
    • 10.1.1. Global Artificial Intelligence (AI) In Drug Discovery Market: Company Market Share, 2019
    • 10.1.2. Global Artificial Intelligence (AI) In Drug Discovery Market, Company Market Revenue, 2016 – 2019 (USD Million)
    • 10.1.3. Global Artificial Intelligence (AI) In Drug Discovery Market, Company Y-o-Y Growth, 2017 – 2019 (%)
    • 10.1.4. Global Artificial Intelligence (AI) In Drug Discovery Market: Radar Determinant Chart, 2019
  • 10.2. Strategic Developments
    • 10.2.1. Acquisitions & Mergers
    • 10.2.2. New Product Launch
    • 10.2.3. Regional Expansion
  • 10.3. Company Strategic Developments – Heat Map Analysis
• CHAPTER NO. 11. COMPANY PROFILES
  • 11.1. IBM Corporation
    • 11.1.1. Company Overview
    • 11.1.2. Key Executives
    • 11.1.3. Product Portfolio
    • 11.1.4. Financial Overview
    • 11.1.5. Operating Business Segments
    • 11.1.6. Business Performance
    • 11.1.7. Recent Developments
  • 11.2. Microsoft
  • 11.3. Google
  • 11.4. NVIDIA Corporation
  • 11.5. Atomwise, Inc.
  • 11.6. Deep Genomics
  • 11.7. Cloud Pharmaceuticals
  • 11.8. Insilico Medicine
  • 11.9. Benevulent AI
  • 11.10. Exscientia
  • 11.11. Cyclica
  • 11.12. BIOAGE
• CHAPTER NO. 12. MARKETING STRATEGY ANALYSIS
  • 12.1. Marketing Channel
  • 12.2. Direct Marketing
  • 12.3. Indirect Marketing
  • 12.4. Marketing Channel Development Trends
  • 12.5. Economic/Pulitical Environmental Change
• CHAPTER NO. 13. RESEARCH METHODulOGY
  • 13.1. Research Methodology
  • 13.2. Phase I - Secondary Research
  • 13.3. Phase II - Data Modeling
    • 13.3.1. Company Share Analysis Model
    • 13.3.2. Revenue Based Modeling
  • 13.4. Phase III - Primary Research
  • 13.5. Research Limitations
    • 13.5.1. Assumptions

Table Of Figures

List of Figures 

FIG NO. 1. Market Attractiveness Analysis, By Drug Type
FIG NO. 2. Market Attractiveness Analysis, By Offering
FIG NO. 3. Market Attractiveness Analysis, By Application
FIG NO. 4. Market Attractiveness Analysis, By End User
FIG NO. 5. Market Attractiveness Analysis, By Region
FIG NO. 6. Global Artificial Intelligence (AI) In Drug Discovery Market Revenue, 2016 – 2028 (USD Million)
FIG NO. 7. Impact of COVID-19 Pandemic in North America Countries
FIG NO. 8. Market Revenue Share, By Drug Type, 2020 & 2028
FIG NO. 9. Global Artificial Intelligence (AI) In Drug Discovery Market for Large Molecules, Revenue (USD Million) 2016 – 2028
FIG NO. 10. Comparative Revenue Analysis of Artificial Intelligence (AI) In Drug Discovery Market for Large Molecules, By Country, 2020 & 2028
FIG NO. 11. Global Artificial Intelligence (AI) In Drug Discovery Market for Small Molecules, Revenue (USD Million) 2016 – 2028
FIG NO. 12. Comparative Revenue Analysis of Artificial Intelligence (AI) In Drug Discovery Market for Small Molecules, By Country, 2020 & 2028
FIG NO. 13. Market Revenue Share, By Offering, 2020 & 2028
FIG NO. 14. Global Artificial Intelligence (AI) In Drug Discovery Market for Software, Revenue (USD Million) 2016 – 2028
FIG NO. 15. Comparative Revenue Analysis of Artificial Intelligence (AI) In Drug Discovery Market for Software, By Country, 2020 & 2028
FIG NO. 16. Global Artificial Intelligence (AI) In Drug Discovery Market for Services, Revenue (USD Million) 2016 – 2028
FIG NO. 17. Comparative Revenue Analysis of Artificial Intelligence (AI) In Drug Discovery Market for Services, By Country, 2020 & 2028
FIG NO. 18. Market Revenue Share, By Application, 2020 & 2028
FIG NO. 19. Global Artificial Intelligence (AI) In Drug Discovery Market for Immuno-oncology, Revenue (USD Million) 2016 – 2028
FIG NO. 20. Comparative Revenue Analysis of Artificial Intelligence (AI) In Drug Discovery Market for Immuno-oncology, By Country, 2020 & 2028
FIG NO. 21. Global Artificial Intelligence (AI) In Drug Discovery Market for Neurodegenerative Diseases, Revenue (USD Million) 2016 – 2028
FIG NO. 22. Comparative Revenue Analysis of Artificial Intelligence (AI) In Drug Discovery Market for Neurodegenerative Diseases, By Country, 2020 & 2028
FIG NO. 23. Global Artificial Intelligence (AI) In Drug Discovery Market for Cardiovascular Diseases, Revenue (USD Million) 2016 – 2028
FIG NO. 24. Comparative Revenue Analysis of Artificial Intelligence (AI) In Drug Discovery Market for Cardiovascular Diseases, By Country, 2020 & 2028
FIG NO. 25. Global Artificial Intelligence (AI) In Drug Discovery Market for Metabolic Diseases, Revenue (USD Million) 2016 – 2028
FIG NO. 26. Comparative Revenue Analysis of Artificial Intelligence (AI) In Drug Discovery Market for Metabolic Diseases, By Country, 2020 & 2028
FIG NO. 27. Global Artificial Intelligence (AI) In Drug Discovery Market for Other Applications, Revenue (USD Million) 2016 – 2028
FIG NO. 28. Comparative Revenue Analysis of Artificial Intelligence (AI) In Drug Discovery Market for Other Applications, By Country, 2020 & 2028
FIG NO. 29. Market Revenue Share, By End User, 2020 & 2028
FIG NO. 30. Global Artificial Intelligence (AI) In Drug Discovery Market for Pharmaceutical & Biotechnology Companies, Revenue (USD Million) 2016 – 2028
FIG NO. 31. Comparative Revenue Analysis of Artificial Intelligence (AI) In Drug Discovery Market for Pharmaceutical & Biotechnology Companies, By Country, 2020 & 2028
FIG NO. 32. Global Artificial Intelligence (AI) In Drug Discovery Market for Contract Research Organizations, Revenue (USD Million) 2016 – 2028
FIG NO. 33. Comparative Revenue Analysis of Artificial Intelligence (AI) In Drug Discovery Market for Contract Research Organizations, By Country, 2020 & 2028
FIG NO. 34. Global Artificial Intelligence (AI) In Drug Discovery Market for Research Centers and Academic & Government Institutes, Revenue (USD Million) 2016 – 2028
FIG NO. 35. Comparative Revenue Analysis of Artificial Intelligence (AI) In Drug Discovery Market for Research Centers and Academic & Government Institutes, By Country, 2020 & 2028
FIG NO. 36. Global Artificial Intelligence (AI) In Drug Discovery Market Revenue Share, By Region, 2020 & 2028
FIG NO. 37. North America Artificial Intelligence (AI) In Drug Discovery Market Revenue, 2016 - 2028 (USD Million)
FIG NO. 38. Porter’s Five Forces Analysis for Global Artificial Intelligence (AI) In Drug Discovery Market
FIG NO. 39. PEST Analysis for Global Artificial Intelligence (AI) In Drug Discovery Market
FIG NO. 40. Pricing Analysis for Global Artificial Intelligence (AI) In Drug Discovery Market
FIG NO. 41. Value Chain Analysis for Global Artificial Intelligence (AI) In Drug Discovery Market
FIG NO. 42. Company Share Analysis, 2019
FIG NO. 43. Radar Determinant Chart, 2019
FIG NO. 44. Company Strategic Developments – Heat Map Analysis
FIG NO. 45. IBM Corporation Business Segment Revenue Share, 2020 (%)
FIG NO. 46. IBM Corporation Geographical Segment Revenue Share, 2020 (%)
FIG NO. 47. Market Channels
FIG NO. 48. Marketing Channel Development Trend
FIG NO. 49. Growth in World Gross Product, 2008-2018
FIG NO. 50. Research Methodology – Detailed View
FIG NO. 51. Research Methodology
 
 

Table Of Tables

List of Tables 

TABLE NO. 1. Global Artificial Intelligence (AI) In Drug Discovery Market: Snapshot
TABLE NO. 2. Quarterly Artificial Intelligence (AI) In Drug Discovery Market Revenue by Region, 2020
TABLE NO. 3. Quarterly Artificial Intelligence (AI) In Drug Discovery Market Revenue Forecast by Region, 2021
TABLE NO. 4. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Million)
TABLE NO. 5. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Million)
TABLE NO. 6. Global Artificial Intelligence (AI) In Drug Discovery Market for Large Molecules, by Region, 2016 – 2028 (USD Million)
TABLE NO. 7. Global Artificial Intelligence (AI) In Drug Discovery Market for Small Molecules, by Region, 2016 – 2028 (USD Million)
TABLE NO. 8. Global Artificial Intelligence (AI) In Drug Discovery Market for Software, by Region, 2016 – 2028 (USD Million)
TABLE NO. 9. Global Artificial Intelligence (AI) In Drug Discovery Market for Services, by Region, 2016 – 2028 (USD Million)
TABLE NO. 10. Global Artificial Intelligence (AI) In Drug Discovery Market for Immuno-oncology, by Region, 2016 – 2028 (USD Million)
TABLE NO. 11. Global Artificial Intelligence (AI) In Drug Discovery Market for Neurodegenerative Diseases, by Region, 2016 – 2028 (USD Million)
TABLE NO. 12. Global Artificial Intelligence (AI) In Drug Discovery Market for Cardiovascular Diseases, by Region, 2016 – 2028 (USD Million)
TABLE NO. 13. Global Artificial Intelligence (AI) In Drug Discovery Market for Metabolic Diseases, by Region, 2016 – 2028 (USD Million)
TABLE NO. 14. Global Artificial Intelligence (AI) In Drug Discovery Market for Other Applications, by Region, 2016 – 2028 (USD Million)
TABLE NO. 15. Global Artificial Intelligence (AI) In Drug Discovery Market for Pharmaceutical & Biotechnology Companies, by Region, 2016 – 2028 (USD Million)
TABLE NO. 16. Global Artificial Intelligence (AI) In Drug Discovery Market for Contract Research Organizations, by Region, 2016 – 2028 (USD Million)
TABLE NO. 17. Global Artificial Intelligence (AI) In Drug Discovery Market for Research Centers and Academic & Government Institutes, by Region, 2016 – 2028 (USD Million)
TABLE NO. 18. Global Artificial Intelligence (AI) In Drug Discovery Market Revenue, By Region, 2016 – 2028 (USD Million)
TABLE NO. 19. North America Artificial Intelligence (AI) In Drug Discovery Market Revenue, By Country, 2016 – 2028 (USD Million)
TABLE NO. 20. North America Artificial Intelligence (AI) In Drug Discovery Market Revenue, By Drug Type, 2016 – 2028 (USD Million)
TABLE NO. 21. North America Artificial Intelligence (AI) In Drug Discovery Market Revenue, By Offering, 2016 – 2028 (USD Million)
TABLE NO. 22. North America Artificial Intelligence (AI) In Drug Discovery Market Revenue, By Application, 2016 – 2028 (USD Million)
TABLE NO. 23. North America Artificial Intelligence (AI) In Drug Discovery Market Revenue, By End User, 2016 – 2028 (USD Million)
TABLE NO. 24. U.S. Artificial Intelligence (AI) In Drug Discovery Market Revenue, By Drug Type, 2016 – 2028 (USD Million)
TABLE NO. 25. U.S. Artificial Intelligence (AI) In Drug Discovery Market Revenue, By Offering, 2016 – 2028 (USD Million)
TABLE NO. 26. U.S. Artificial Intelligence (AI) In Drug Discovery Market Revenue, By Application, 2016 – 2028 (USD Million)
TABLE NO. 27. U.S. Artificial Intelligence (AI) In Drug Discovery Market Revenue, By End User, 2016 – 2028 (USD Million)
TABLE NO. 28. Canada Artificial Intelligence (AI) In Drug Discovery Market Revenue, By Drug Type, 2016 – 2028 (USD Million)
TABLE NO. 29. Canada Artificial Intelligence (AI) In Drug Discovery Market Revenue, By Offering, 2016 – 2028 (USD Million)
TABLE NO. 30. Canada Artificial Intelligence (AI) In Drug Discovery Market Revenue, By Application, 2016 – 2028 (USD Million)
TABLE NO. 31. Canada Artificial Intelligence (AI) In Drug Discovery Market Revenue, By End User, 2016 – 2028 (USD Million)
TABLE NO. 32. Mexico Artificial Intelligence (AI) In Drug Discovery Market Revenue, By Drug Type, 2016 – 2028 (USD Million)
TABLE NO. 33. Mexico Artificial Intelligence (AI) In Drug Discovery Market Revenue, By Offering, 2016 – 2028 (USD Million)
TABLE NO. 34. Mexico Artificial Intelligence (AI) In Drug Discovery Market Revenue, By Application, 2016 – 2028 (USD Million)
TABLE NO. 35. Mexico Artificial Intelligence (AI) In Drug Discovery Market Revenue, By End User, 2016 – 2028 (USD Million)
TABLE NO. 36. Drivers for the Artificial Intelligence (AI) In Drug Discovery Market: Impact Analysis
TABLE NO. 37. Restraints for the Artificial Intelligence (AI) In Drug Discovery Market: Impact Analysis
TABLE NO. 38. Major Buyers of Artificial Intelligence (AI) In Drug Discovery
TABLE NO. 39. Distributors/Traders List of Artificial Intelligence (AI) In Drug Discovery
TABLE NO. 40. Global Artificial Intelligence (AI) In Drug Discovery Market, Company Market Revenue, 2016 – 2019 (USD Million)
TABLE NO. 41. Global Artificial Intelligence (AI) In Drug Discovery Market, Company Y-o-Y Growth, 2017 – 2019 (USD Million)